Healthcare provider profile · identity verified

Matthew S Farmer, MD

Internal Medicine · ATHENS, GA · NPI 1316233323

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	549	153
Amlodipine Besylate	Amlodipine Besylate	494	143
Losartan Potassium	Losartan Potassium	420	122
Levothyroxine Sodium	Levothyroxine Sodium	330	92
Rosuvastatin Calcium	Rosuvastatin Calcium	291	91
Omeprazole	Omeprazole	256	74
Lisinopril	Lisinopril	252	71
Metformin Hcl	Metformin Hcl	216	58
Gabapentin	Gabapentin	192	54
Tramadol Hcl	Tramadol Hcl	191	46
Tamsulosin Hcl	Tamsulosin Hcl	187	60
Trazodone Hcl	Trazodone Hcl	166	57
Pantoprazole Sodium	Pantoprazole Sodium	158	49
Albuterol Sulfate Hfa	Albuterol Sulfate	156	50
Metoprolol Succinate	Metoprolol Succinate	156	46
Pravastatin Sodium	Pravastatin Sodium	154	41
Escitalopram Oxalate	Escitalopram Oxalate	150	40
Furosemide	Furosemide	138	42
Famotidine	Famotidine	132	43
Hydrochlorothiazide	Hydrochlorothiazide	127	41
Simvastatin	Simvastatin	122	34
Ozempic	Semaglutide	120	24
Sertraline Hcl	Sertraline Hcl	116	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	106	32
Meloxicam	Meloxicam	106	31
Potassium Chloride	Potassium Chloride	106	27
Bupropion Xl	Bupropion Hcl	97	27
Metformin Hcl Er	Metformin Hcl	96	27
Olmesartan Medoxomil	Olmesartan Medoxomil	92	28
Allopurinol	Allopurinol	91	25
Montelukast Sodium	Montelukast Sodium	87	27
Metoprolol Tartrate	Metoprolol Tartrate	86	25
Alprazolam	Alprazolam	85	26
Glimepiride	Glimepiride	79	24
Eliquis	Apixaban	76	21
Clopidogrel	Clopidogrel Bisulfate	74	23
Jardiance	Empagliflozin	73	17
Atenolol	Atenolol	72	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	36
Ezetimibe	Ezetimibe	67	20
Zolpidem Tartrate	Zolpidem Tartrate	67	25
Clonazepam	Clonazepam	66	20
Methylprednisolone	Methylprednisolone	66	57
Carvedilol	Carvedilol	64	20
Fluticasone Propionate	Fluticasone Propionate	62	19
Buspirone Hcl	Buspirone Hcl	61	14
Synthroid	Levothyroxine Sodium	60	14
Lorazepam	Lorazepam	58	21
Citalopram Hbr	Citalopram Hydrobromide	56	15
Azelastine Hcl	Azelastine Hcl	54	28
Trulicity	Dulaglutide	54	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	51	14
Chlorthalidone	Chlorthalidone	50	15
Fluoxetine Hcl	Fluoxetine Hcl	50	16
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	50	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	46	14
Tizanidine Hcl	Tizanidine Hcl	45	14
Xarelto	Rivaroxaban	45	11
Prednisone	Prednisone	44	29
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	44	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	21
Duloxetine Hcl	Duloxetine Hcl	42	15
Esomeprazole Magnesium	Esomeprazole Magnesium	42	16
Estradiol	Estradiol	42	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Azithromycin	Azithromycin	40	32
Alendronate Sodium	Alendronate Sodium	39	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	suppressed
Glipizide	Glipizide	38	12
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	13
Clonidine Hcl	Clonidine Hcl	33	11
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Farxiga	Dapagliflozin Propanediol	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	29
Mounjaro	Tirzepatide	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	30	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Pregabalin	Pregabalin	28	suppressed
Cefdinir	Cefdinir	27	19
Januvia	Sitagliptin Phosphate	27	suppressed
Naproxen	Naproxen	27	15
Propranolol Hcl	Propranolol Hcl	27	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	19
Baclofen	Baclofen	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Nystatin	Nystatin	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Arnuity Ellipta	Fluticasone Furoate	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	14
Finasteride	Finasteride	21	11
Spironolactone	Spironolactone	21	suppressed
Eszopiclone	Eszopiclone	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	11
Premarin	Estrogens, Conjugated	20	suppressed
Ramipril	Ramipril	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Glipizide Er	Glipizide	18	suppressed
Ondansetron Odt	Ondansetron	18	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	12
Testosterone	Testosterone	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Cephalexin	Cephalexin	17	15
Dropsafe Prep Pads	Alcohol Antiseptic Pads	17	suppressed
Fluconazole	Fluconazole	17	15
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Valsartan	Valsartan	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Enalapril Maleate	Enalapril Maleate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Risperidone	Risperidone	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Diazepam	Diazepam	13	suppressed
Linzess	Linaclotide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Epinephrine	Epinephrine	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Mupirocin	Mupirocin	12	12
Nifedipine Er	Nifedipine	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Wegovy	Semaglutide	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	11	suppressed
Primidone	Primidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error